Inpatient antibiotic utilization in the Veterans’ Health Administration during the coronavirus disease 2019 (COVID-19) pandemic
Thomas D Dieringer, Daisuke Furukawa, Christopher J. Graber, Vanessa Stevens, Makoto Jones, Michael Rubin, Matthew Bidwell Goetz
Abstract
Antibiotic prescribing practices across the Veterans' Health Administration (VA) experienced significant shifts during the coronavirus disease 2019 (COVID-19) pandemic. From 2015 to 2019, antibiotic use between January and May decreased from 638 to 602 days of therapy (DOT) per 1,000 days present (DP), while the corresponding months in 2020 saw antibiotic utilization rise to 628 DOT per 1,000 DP.
Topics & Concepts
PandemicCoronavirus disease 2019 (COVID-19)MedicineAntibioticsCoronavirus2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Administration (probate law)DiseaseEmergency medicineIntensive care medicineVirologyInfectious disease (medical specialty)Internal medicineMicrobiologyOutbreakBiologyLawPolitical scienceAntibiotic Use and ResistancePatient Satisfaction in HealthcarePharmaceutical Practices and Patient Outcomes